Libertas Academica now offers useful optional services for authors. They're intended to help you prepare your manuscript for peer review or respond to peer reviewers' recommendations.
These are available to all authors. You don't even need to have submitted--or be intending to submit--your paper to one of our journals.
Pre-peer review copy editing:
This is done by proficient native English language speaking technical editors.
Pre-peer review reference formatting:
Also done by technical editors who are familiar with all common reference formatting standards.
Post-peer review revised manuscript preparation:
Too busy to prepare a revised version of your manuscript in response to the reviewers’ recommendations, or not sufficiently confident of your English?
This innovative service is provided by our business partner, who is a highly experienced former academic with a network of fellow academics working in every area Libertas Academica publishes journals in.
Your manuscript and the peer reviewers’ report will be sent to our business partner and a resubmission-ready package of files will be returned for your review prior to resubmission. Our staff will liase with you directly if access to any research source material is required.
Post-peer review copy editing and reference formatting:
These services are also available after peer review. Supply our technical editors with your peer review report to ensure they address the reviewers' points.
Bound reprints:
Distributing printed copies of an article is a great way to bring it to the attention of your colleagues at your institution or during meetings and conferences. We can supply spine-bound, high resolution black and white or colour copies of your article in sharp digital reprography.
Other pages can also be added to the back or front of your article, such as your CV or biosketch, and covers and various delivery options are also available.
Click here to get a no-obligation quote.
Thursday, March 26, 2009
Newsletter summary (Week 13, 2009)
Journal newsletters sent in week 13:
- Breast Cancer: Basic and Clinical Research
- Biomarker Insights
- Bone and Tissue Regeneration Insights
- Cancer Informatics
- Clinical Medicine: Case Reports
- Clinical Medicine: Geriatrics
- Clinical Medicine: Oncology
- Clinical Medicine: Pediatrics
- Clinical Medicine: Therapeutics
- Evolutionary Bioinformatics
- Genetics and Epigenetics
- International Journal of Tryptophan Research
- Open Journal of Cardiovascular Surgery
- Palliative Care: Research and Treatment
- Proteomics Insights
- Substance Abuse: Research and Treatment
- Tobacco Use Insights
- Notifications of new articles
- News items
- Reminder of call for papers
- No graphics, no HTML, clear and consise. Designed to be read quickly.
- Relevant, up-to-date content. No third-party advertising.
- Unsubscribe at anytime through My LA or the newsletter's unsubscribe link.
- Written and sent by me. Recipients' replies come directly to me.
- Your privacy is important: your details will not be shared with third parties.
Wednesday, March 25, 2009
New journal Glycobiology Insights is under development
I'm pleased to announce that Libertas Academica has commenced development of a new journal, Glycobiology Insights.
The journal was suggested by Dr Hafiz Ahmed, who has worked in this area for 25 years, and is also the Editor in Chief of Organic Chemistry Insights.
To be informed of the progress of the journal, including the publication of the first papers, please register to receive the journal's newsletter.
Editorial Board members sought:
We seek editorial board members.
More about Glycobiology Insights:
The journal was suggested by Dr Hafiz Ahmed, who has worked in this area for 25 years, and is also the Editor in Chief of Organic Chemistry Insights.
To be informed of the progress of the journal, including the publication of the first papers, please register to receive the journal's newsletter.
Editorial Board members sought:
We seek editorial board members.
More about Glycobiology Insights:
Genetics and Epigenetics launched
I'm pleased to announce the launch of Genetics and Epigenetics, an open access peer reviewed journal published by Libertas Academica. The journal is fortunate to have the support of an excellent Editor in Chief, Dr Christian Bronner, and an internationally respected editorial board. An interview with the Editor in Chief will be published shortly.
Register to receive automatic notification of new articles and journal news. The Editor in Chief's introductory editorial is now available.
The Editor in Chief writes:
Register to receive automatic notification of new articles and journal news. The Editor in Chief's introductory editorial is now available.
The Editor in Chief writes:
I proudly announce the launch of Genetics & Epigenetics, a new peer-reviewed open-access journal published by Libertas Academica. Epigenetics is beginning to take shape as a new scientific discipline, which will have profound impact on our understanding of genetics.I look forward to working with the journal's Editor in Chief, editorial board and authors and readers.
Epigenetics and genetics have deeply improved our understanding of the molecular mechanisms occurring in several pathologies such as cancer, neurological diseases, cardiovascular diseases and allergy as well as in physiologic processes such as development. The frontier between genetics and epigenetics is beginning to disappear as these two disciplines are becoming more and more complementary to each other. Hence, the journal goal is to facilitate this disappearance by publishing works of high quality that are at the cutting-edge of these two fields. As knowledge’s in the field of Genetics and Epigenetics are rapidly and dramatically increasing, Genetics and Epigenetics offers both fast reviewing and rapid open access of manuscripts after acceptance. One of the priorities of the journal is to decrease the time from manuscript submission to article publication.
Monday, March 23, 2009
Dennis Wall new Editor in Chief of Evolutionary Bioinformatics
I'm pleased to announce the appointment of Dr Dennis Wall to the position of Editor in Chief of Evolutionary Bioinformatics, a peer reviewed open access electronic journal published by Libertas Academica.
Dr Wall is a member of the faculty at the Center for Biomedical Informatics at Harvard Medical School where he runs a research lab in translational and evolutionary bioinformatics. He has published on a diverse set of topics in the areas of evolutionary biology and network analysis of disease, and has created widely used resources for both evolutionary and translational research, most notably Roundup and Autworks.
He has received numerous grants and awards, including an NSF postdoctoral fellowship in biological informatics, the Fred R. Cagle Award for Outstanding Achievement in Biology, the Vice Chancellor's Award for Research, several awards for excellence in teaching, and a Harvard Leadership award.
I look forward to working with Dr Wall to further strengthen this already highly successful journal.
I also thank the founding Editor in Chief, Dr Mark Pagel, for his support and assistance following the launching of the journal in 2005. Dr Pagel remains on the Editorial Board as Founding Editor in Chief.
- Indexed by 12 major databases including Pubmed
- Most popular article read more than 3200 times
- Established in 2005
- Editorial decisions on papers in 2 weeks for 90% of submissions
An interview with Dr Kerstin Rolfe
This interview is with Dr Kerstin Rolfe, Editor in Chief of Bone and Tissue Regeneration Insights and a Group Leader in Tissue Regeneration through the Restoration of Appearance and Function Trust (RAFT), Mount Vernon Hospital, in the UK. She is also an Honorary Lecturer on the subject at University College London.Tom: What would you say is the primary focus of your research effort (and how do you refer to your 'sub-area')?
My area is on preventing scarring both dermal and in tendons. My main focus is studying why some human tissues can regenerate without the formation of scar tissue and this has involved studying a number of signalling pathways and how the manipulation of these can alter cellular behaviour.
Tom: What do you consider to be the most significant developments arising from research in your area?
Science moves on with such a pace and the new technological advancements has helped provide answers which before would have taken years if we indeed could actually answer the question.
Tom: What do you consider to be the most significant open questions and research challenges in your area?
To move from the laboratory into clinical practice.
Tom: Tell us about your collaborative research. Who else do you directly work with and what are the aims of your collaboration?
I work particularly with a number of clinicians who are both helpful in providing clinical samples but also ensure that my research could benefit patients in the long-term and they can have some interesting and novel ideas.
Tom: Is balancing all these activities challenging? How do you deal with it and what tools do you find useful in doing so?
I have a very supportive and understanding husband and circle of friends who are used to me working long odd hours. I also borrow the saying from Robert Collier ‘Success is the sum of small efforts repeated day in and day out’.
I also love technology and all the latest gadgets and the one that has revolutionised my life is my iphone and 3G!
Tom: When did you decide to be primarily involved in the field that you are now in?
I actually left school trained and worked as a nurse, which I really enjoyed but decided I wanted to play a different part in helping patients. So in the evenings undertook a part time BSc (Hons), I was luck enough after being awarded my degree and being awarded a fellowship to study for a PhD, which was actually in cancer. My first post-doctoral job started me off in this field and I caught the bug and so I have just continued.
Tom: What resources do you find indispensable for your research work?
Funding is of vital importance, the Internet and support from colleagues and friends.
Tom: What do you think about the development of open access publishing and open access development? How has it changed your perspective on research or development practices?
Open access is great as it allows scientists access to publications without the conventional boundaries. It also allows those long wait for publications to be reduced both for the authors and the science community speeding up the dissemination of vital information.
Tom: What books do you think should be required reading for researchers working in your area?
I dip in and out of text books and find that I use science papers in the main.
Tom: What books are current on your reading list?
I have just completed a LLM in medical law and ethics so for a break I have started reading history based books currently I am reading "Henry: The Virtuous Prince" by David Starkey (Amazon.com) and I love Sherlock Holmes so I am also reading "Sherlock Holmes: The Unauthorized Biography" by Nick Rennison (Amazon.com).
Tom: Do you teach any courses? Is so, which ones?
My current job does not involve teaching responsibilities as such but I have a role in teaching junior staff and supervising post-graduate students.
Tom: Which historical research figures do you think have most influenced you in how you think about research? Why are they significant?
Leonardo da Vinci whose ideas were so advanced for the time and his breadth of talents are to me both outstanding and inspirational.
Rosalind Franklin who contributed to the understanding of DNA structure but also she later worked in the college where I studied for my degree but sadly she died at only 37 years.
And of course I cannot miss out Darwin.
Tom: Which meetings do you attend on a regular basis?
Mostly European meetings involved in dermatological research though I also try to go to some clinical meetings which are useful for bringing me back to the clinical need and reality.
Tom: If you could change something about how research in your area is conducted, used, perceived, or resourced, what would it be?
It would be great not to have to worry about funding.
My thanks to Dr Rolfe.
Thursday, March 19, 2009
Bone and Tissue Regeneration Insights launched
I'm pleased to announce the launch of Bone and Tissue Regeneration Insights, an open access peer reviewed journal published by Libertas Academica. The journal is fortunate to have the support of an excellent Editor in Chief, Dr Kerstin Rolfe, and an internationally respected editorial board. An interview with the Editor in Chief will be published shortly.
Register to receive automatic notification of new articles and journal news. The Editor in Chief's introductory editorial is now available. The Editor in Chief writes:
Register to receive automatic notification of new articles and journal news. The Editor in Chief's introductory editorial is now available. The Editor in Chief writes:
I am proud to announce the launch of Bone and Tissue Regeneration Insights, a new peer-reviewed open access journal published by Libertas Academica. The journal will cover research from healing to regeneration of all tissues and is keen to encourage participation from all disciplines and professions involved in regeneration. Tissue regeneration is an expanding and exciting field with a number of novel technologies being exploited and it is therefore an ideal time to launch a new journal in this fast moving field. The open access nature of the journal allows all original and review articles to be accessible to all Internet users worldwide and the rapid review of papers and publication of accepted articles will allow articles to be available rapidly and allow the diffusion of research to a greater audience.I look forward to working with the journal's Editor in Chief, editorial board and authors and readers.
About provisional PDFs
I've received a few questions lately about the status of provisional PDFs. For those not familiar with them, they are the version of the manuscript that is published immediately upon the paper being accepted for publication.
Provisional PDFs are made up of the accepted version of the manuscript, any other files comprising the submission, plus a cover sheet. As soon as the typeset version of the article is ready it replaces the provisional PDF.
Benefits of provisional PDFs:
In light of this we decided earlier this year to cease providing provisional PDFs. However, authors who specifically require it may request it during the publication process and we will be happy to provide one.
Provisional PDFs are made up of the accepted version of the manuscript, any other files comprising the submission, plus a cover sheet. As soon as the typeset version of the article is ready it replaces the provisional PDF.
Benefits of provisional PDFs:
- Means that the paper is published as rapidly as possible.
- In some areas, it may be useful for authors to 'plant their flag' in an area as soon as possible.
- Manuscripts vary widely in presentation and some authors may prefer that their manuscript is not made public.
- While we can tidy up some manuscripts--depending on file format--this effectively means we have to typeset the same paper twice: the final typeset PDF and the provisional PDF. If we have to typeset twice a delay is added to the publication process which undermines the benefit of providing a provisional PDF.
- Cannot be cited because pagination is unknown until the final typeset paper is completed.
- May be confused for the final typeset version of the paper.
In light of this we decided earlier this year to cease providing provisional PDFs. However, authors who specifically require it may request it during the publication process and we will be happy to provide one.
Six more journals now in EBSCO Academic Research Complete
Six electronic, open access journals published by Libertas Academica have been accepted for indexing in EBSCO's Academic Research Complete database:
- Biomarker Insights
- Cancer Informatics
- Drug Target Insights
- Gene Regulation and Systems Biology
- Integrative Medicine Insights
- Translational Oncogenomics
- 5,500 full text periodicals
- 4,600 peer-reviewed journals
- Abstracts for more than 9,500 journals
- 10,000 publications including monographs, reports, conference proceedings
- Native searchable PDFs content back to 1887
New Associate Editor for Biomarker Insights and Immunotherapy Insights
I'm pleased to announce the appointment of Dr Barbara Guinn to the position of Associate Editor of Immunotherapy Insights, open access electronic journals published by Libertas Academica.
Dr. Guinn is a Senior Research Fellow at The University of Southampton and a visiting scientist at King’s College London. Dr. Guinn gained her B.Sc. in Genetics from the University of Wales, Aberystwyth in 1991 and a Ph.D. in Medicine from the University of Wales College of Medicine, Cardiff in 1995. Dr. Guinn was one of the first Leukaemia Research Fund Gordon Piller Ph.D. students in the year this prestigious award was initiated. Dr. Guinn undertook two postdoctoral fellowships at the University of Toronto (Autologous Bone Marrow Transplant Unit, Toronto General Hospital and Department of Immunology) and has maintained a history of support from the Leukaemia Research Fund throughout her career. In addition, Dr Guinn has received funding from Cancer Research U.K., the Elimination of Leukaemia Fund, Wessex Cancer Trust and British Society for Haematology. Dr. Guinn has published over 50 peer-reviewed manuscripts. She is on the editorial board of five journals and reviews manuscripts for more than 30 scientific journals on an ad hoc basis.
Dr. Guinn’s research at King’s College London, and more recently at the University of Southampton, has focused on the identification of leukaemia antigens in acute myeloid leukaemia using SEREX, microarray and RT-PCR. A number of epitopes from these antigens have been inserted into DNA vaccines and tested for suitability for near-future clinical trials. Dr. Guinn’s group has also worked on whole cell vaccines for acute myeloid leukaemia and B-cell lymphoma, and the development of tetramer arrays as a clinical end-point assay.
Dr Guinn brings a great deal of enthusiasm and experience to this role and will further strengthen these already strong journals.
Dr. Guinn is a Senior Research Fellow at The University of Southampton and a visiting scientist at King’s College London. Dr. Guinn gained her B.Sc. in Genetics from the University of Wales, Aberystwyth in 1991 and a Ph.D. in Medicine from the University of Wales College of Medicine, Cardiff in 1995. Dr. Guinn was one of the first Leukaemia Research Fund Gordon Piller Ph.D. students in the year this prestigious award was initiated. Dr. Guinn undertook two postdoctoral fellowships at the University of Toronto (Autologous Bone Marrow Transplant Unit, Toronto General Hospital and Department of Immunology) and has maintained a history of support from the Leukaemia Research Fund throughout her career. In addition, Dr Guinn has received funding from Cancer Research U.K., the Elimination of Leukaemia Fund, Wessex Cancer Trust and British Society for Haematology. Dr. Guinn has published over 50 peer-reviewed manuscripts. She is on the editorial board of five journals and reviews manuscripts for more than 30 scientific journals on an ad hoc basis.
Dr. Guinn’s research at King’s College London, and more recently at the University of Southampton, has focused on the identification of leukaemia antigens in acute myeloid leukaemia using SEREX, microarray and RT-PCR. A number of epitopes from these antigens have been inserted into DNA vaccines and tested for suitability for near-future clinical trials. Dr. Guinn’s group has also worked on whole cell vaccines for acute myeloid leukaemia and B-cell lymphoma, and the development of tetramer arrays as a clinical end-point assay.
Dr Guinn brings a great deal of enthusiasm and experience to this role and will further strengthen these already strong journals.
Wednesday, March 18, 2009
Newsletter summary (week 12, 2009)
Journal newsletters sent in week 12:
- Proteomics Insights
- Reproductive Biology Insights
- Retrovirology: Research and Treatment
- Substance Abuse: Research and Treatment
- Signal Transduction Insights
- Translational Oncogenomics
- Virology: Research and Treatment
- Cancer Informatics
- Clinical Medicine: Endocrinology and Diabetes
- Clinical Medicine: Geriatrics
- Gene Regulation and Systems Biology
- Immunology and Immunogenetics Insights
- Notifications of new articles
- News items
- Reminder of call for papers
- No graphics, no HTML, clear and consise. Designed to be read quickly.
- Relevant, up-to-date content. No third-party advertising.
- Unsubscribe at anytime through My LA or the newsletter's unsubscribe link.
- Written and sent by me. Recipients' replies come directly to me.
- Your privacy is important: your details will not be shared with third parties.
Friday, March 13, 2009
Newsletter summary (week 11, 2009)
Journal newsletters sent in week 11:
These general newsletters contained:
These general newsletters contained:
- Notifications of new articles
- News items
- Reminder of call for papers
- No graphics, no HTML, clear and consise. Designed to be read quickly.
- Relevant, up-to-date content. No third-party advertising.
- Unsubscribe at anytime through My LA or the newsletter's unsubscribe link.
- Written and sent by me. Recipients' replies come directly to me.
- Your privacy is important: your details will not be shared with third parties.
Thursday, March 12, 2009
Cancer Informatics now indexed by Pubmed
I'm pleased to announce that Cancer Informatics, an open access electronic journal published by Libertas Academica, is now indexed by Pubmed.
The 2008 volume is now located on Pubmed with the remainder of articles, including the 2009 and the entire backfile, will be added shortly once XML conversion and validation is completed.
Update:
The 2005 backfile is now available on Pubmed. (30/3/09)
The 2009 backfile is now available on Pubmed. (14/4/09)
The 2008 volume is now located on Pubmed with the remainder of articles, including the 2009 and the entire backfile, will be added shortly once XML conversion and validation is completed.
Update:
The 2005 backfile is now available on Pubmed. (30/3/09)
The 2009 backfile is now available on Pubmed. (14/4/09)
Wednesday, March 11, 2009
Editorial Board members sought
We seek Editorial Board members for the following new journals:
You must be able to demonstrate at least 5 years relevant post-doctoral experience. Complete this form to register.
- Bone and Tissue Regeneration Insights
- Cancer Growth and Metastasis
- Clinical Medicine: Women's Health
- Cell and Tissue Transplantation and Therapy
- Gastrointestinal Cancer Insights
- Genetics and Epigenetics
- Gene Expression to Genetical Genomics
- Human Parasitic Diseases
- International Journal of Cell Division
- International Journal of Pain
- Journal of Brain Disease
- Lymphoma and Chronic Lymphocytic Leukemias
- Musculoskeletal and Spinal Diseases
- Obesity Insights
- Open Journal of Cardiac Surgery
- Open Journal of Multidisciplinary Modeling
- Open Journal of Minimally Invasive Surgery
- Open Journal of Pelvic Surgery
- Phenotype and Gene Expression
- Rehabilitation Process and Outcome
- Tumor Viruses
You must be able to demonstrate at least 5 years relevant post-doctoral experience. Complete this form to register.
Friday, March 6, 2009
Newsletter summary (week 10, 2009)
Journal newsletters sent in week 10:
Publisher's general newsletter:
Publisher's general newsletter:
- Editorial Board members sought
- General newsletter has not been used for over a year, so subscribers were reminded of unsubscription facility if they didn't wish to receive the newsletter.
- Biomarker Insights
- Clinical Medicine: Circulatory, Respiratory and Pulmonary Medicine
- Gene Regulation and Systems Biology
- Health Services Insights
- Infectious Diseases: Research and Treatment
- Immunology and Immunogenetics Insights
- International Journal of Tryptophan Research
- Lipids Insights
- Microbiology Insights
- Medical Equipment Insights
- Magnetic Resonance Insights
- Nutrition and Metabolic Insights
- Organic Chemistry Insights
- Open Journal of Multidisciplinary Modelling
- Palliative Care: Research and Treatment
- Particle Physics Insights
- Biochemistry Insights
- Clinical Medicine: Oncology
- Clinical Medicine: Pediatrics
- Clinical Medicine: Therapeutics
- Journal of Brain Disease
- Perspectives in Medicinal Chemistry
- Notifications of new articles
- News items
- Reminder of call for papers
- No graphics, no HTML, clear and consise. Designed to be read quickly.
- Relevant, up-to-date content. No third-party advertising.
- Unsubscribe at anytime through My LA or the newsletter's unsubscribe link.
- Written and sent by me. Recipients' replies come directly to me.
- Your privacy is important: your details will not be shared with third parties.
Subscribe to:
Posts (Atom)
Posts
